Drug companies reach US$260 million settlement, averting first federal opioid trial

CLEVELAND: Four large drug companies reached a last-minute US$260 million legal settlement over their role in the U.S. opioid addiction epidemic, averting the first federal trial that was scheduled to start Monday morning in Cleveland.

The judge overseeing Monday's trial said he would work out a new trial date for the remaining defendant, pharmacy chain operator Walgreens Boots Alliance Inc . Monday's settlements add to deals worth US$66.4 million that the two counties earlier struck with drug companies Mallinckrodt Plc , Endo International Plc , Johnson & Johnson and Allergan Plc .

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Drug companies reach settlement as opioid trial set to beginThe fight over who is responsible for the opioid epidemic that has ravaged the United States heads to court on Monday in Ohio as local governments ... This settlement will certainly benefit the drug companies and the PSC attorneys at the expense of the plaintiffs. Changsha Hunan
مصدر: ChannelNewsAsia - 🏆 6. / 66 اقرأ أكثر »

Drug companies reach settlement as opioid trial set to beginThe fight over who is responsible for the opioid epidemic that has ravaged the United States heads to court on Monday in Ohio as local governments ... This settlement will certainly benefit the drug companies and the PSC attorneys at the expense of the plaintiffs. Changsha Hunan
مصدر: ChannelNewsAsia - 🏆 6. / 66 اقرأ أكثر »